Finding the right antibody for CUT&RUN

Prev Next

Antibody selection is one of the most important factors in CUT&RUN success. Antibody performance is application-specific, and performance in ChIP-seq does not guarantee success in CUT&RUN. For a more detailed discussion of antibody selection and validation, see our recent CUT&RUN publication [1] and our Tech Support Center articles, Can I use my ChIP antibody for CUTANA™ assays? and What antibody should I use for CUT&RUN?.

When selecting an antibody for your experiment, we recommend the following resources:

  • EpiCypher offers a growing collection of CUT&RUN-validated antibodies, including those to histone PTMs, chromatin modifiers, and transcription factors. This includes our internally developed recombinant monoclonal antibodies to PTMs, and those to chromatin binding proteins validated through our collaboration with Abcam.

  • In addition to the antibodies sold on our website, we have had success in our internal CUT&RUN assays using other vendors' antibodies reagents to targets including: ARID1A, BAF53a, BCLIIA, Biotin, BRD4, BRD9, BRG1, c-Fos, c-Jun, CBP, CDK6, CRCT2, CREBBP, CTNNB1, DNMT3A, EHMT2, ELK1, ELOB, EP300, ESSRRa, EZH2, FOXA1, FOXA2, FOXA3, FOXO3, GLTSCR1, H2BK20ac, H3K23ac, H3K9ac, H3K9me3, HDAC2, HER2, HNF4a, IKZFl, IKZF3, IRF5, KDM6A, MAX, MED1, MED1/TRAP220, MITF, MTOR, MYC, NFIA, NFYA, NKX2.1, NOTCH1, NPAT, NR4A1, P300, p65, PBRM, PBRM1, PGC1a, Rad21, phosphorylated RNA Pol II CTD, RPB1, RPB3, SIRT6, SMAD1, SMAD2, SMAD3, SOX10, SOX2, STAT1, STAT2, SUZ12, TCF7L2, TP63, USP7, and YAP. If you are interested in one of these targets or our recent studies, please reach out to us at techsupport@epicypher.com for details.

  • Cell Signaling Technology also validates many of their antibodies for use in CUT&RUN; however, EpiCypher has not independently tested these for use with our CUT&RUN kits and/or protocols.

  • You can search for your target in our comprehensive database of CUT&RUN and CUT&Tag publications to see what has worked for other researchers. A key consideration when working with antibodies sourced from publications or third-party vendors is that reagent performance can vary between lots, even when the catalog number remains unchanged (this is particularly the case for polyclonal antibodies). We recommend recording both the catalog and lot numbers of any antibodies used in a publication, and if possible obtaining the same lot for your studies. For unvalidated candidate antibodies, or those for which you cannot obtain the same lot, see our guidance for validating chromatin protein antibodies or validating histone PTM antibodies.

References

  1. Firestone et al. High-Efficiency Genomic Mapping of Chromatin-Associated Targets with CUT&RUN. Methods Mol Biol 3005, 99–141 (2026).